The work of the AVAC/PHASES think tank to advance HIV prevention research with pregnant and lactating people was importantly grounded in a trio of conceptual frameworks: 1. Reproductive Justice, 2. Conceptual shifts articulated in the Pregnancy and HIV/AIDS: Seeking Equitable Study (PHASES) Ethics Guidance and 3. WHO/ IMPAACT framework for accelerated inclusion of pregnant women in pre-licensure clinical trials.
Advancing HIV Prevention Research in Pregnant and Lactating People (PLP): Think Tank Report & Action Plan
Faster, Smarter and More Equitable – Accelerating Roll Out and Uptake of CAB for PrEP
Monday, August 8, 2022
As we begin rolling out injectable cabotegravir (CAB) as PrEP, what lessons have we learned from the first 10 years of oral PrEP implementation? How can we do better with a new PrEP intervention that offers new opportunities and distinct challenges? Learn more in this Choice Agenda webinar.
Featuring Rachel Baggaley, Caroline Carnevale, Monica Gandhi and Mitchell Warren
More than Vessels: Pregnant people deserve inclusion in HIV prevention clinical and implementation research
Wednesday, December 14, 2022
During this webinar, panelists explored the need for Pregnant and Lactating Populations (PLP) to be included HIV prevention clinical and implementation research
Speakers included Dr. Elaine Abrams, Raniyah Copeland, Dr. Lisa Noguchi and Dr. Lynda Stranix-Chibanda. The discussion was moderated by Dr. Dvora Joseph Davey.
Status Updates on Ongoing and Planned HIV Prevention Trials
The world is grappling with the far-reaching impacts of the COVID-19 pandemic and the HIV prevention field is no different. Most trials investigating new biomedical HIV prevention products have paused, citing concerns for the safety of trial participants and the study teams.
How COVID-19 is impacting research varies by trial and site, and efforts are ongoing to minimize impact on trial timelines and data. AVAC will continue to monitor developments—watch this space.
COVID-19 Resources for Advocates
This document is to help advocates with links to the latest information about COVID-19, including information on its prevention, transmission, relationship to HIV and research that’s underway. Many of the links below are constantly updated so please click through for the latest.
Picking Up the Pace
PrEP introduction is gaining traction around the world. Check out AVAC’s graphic showing global totals, and the uptick in implementation studies, regulatory approvals, global recommendations and more.
AIDS Vaccines by the Numbers: Trials, discoveries, money and more
We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward. The graphics below represent key facts about the AIDS vaccine field.
Trans Inclusion: Charting HIV Research into the Future: A Manifesto and Scorecard for Advocates and Researchers
Thursday, January 26, 2023
During this webinar, panelists unpacked the No Data No More manifesto and discussed preliminary findings from the TG scorecard, which looked at transgender representation in clinical trials over time. Speaker details, recording, and resources below.
Featured Leigh Ann van der Merwe — Founder and Director: Social, Health & Empowerment Feminist Collective of Transgender Women of Africa; Brian Minalga — AVAC consultant, Trans Inclusion Initiative; and Cindra Feuer — AVAC Senior Program Manager: Partnerships & Capacity Strengthening
Re: Draft Recommendation Statement and Draft Evidence Review: Pre-Exposure Prophylaxis for the Prevention of HIV Infection
AVAC submits comment and response to the United States Preventative Services Task Force (USPSTF) Draft Recommendation statement for PrEP. The USPSTF recommended an “A” Grade for PrEP that includes CAB for PrEP.
HIV Vaccines: An introductory factsheet
This is an updated introductory two-page document that describes HIV vaccines research and reviews key developments in the field.